Home / Companies / Acadia Pharmaceuticals Inc. / 29 May 2024
Acadia Pharmaceuticals Inc.: meeting of 29 May 2024
Votes reported on Form N-PX, item by item
431 Form N-PX filers reported votes at the Acadia Pharmaceuticals Inc. meeting of 29 May 2024. Their records fall into 4 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.
foragainstabstain, withhold or otheramber tick: the portion cast against management
Items
DIRECTOR ELECTIONSIssuer
Director elections
3 nominees; 83.3% of reported votes for; 50 filers withheld from or voted against at least one nominee.
863 vote records from 155 filers. 25 of the 154 filers that marked the item either way voted against management. 1 filer reported this item without a management mark.
SECTION 14A SAY-ON-PAY VOTESIssuer
Advisory vote on executive pay (say-on-pay)
647 vote records from 425 filers. 42 of the 408 filers that marked the item either way voted against management. 17 filers reported this item without a management mark.
AUDIT-RELATEDIssuer
Audit-related items (auditor ratification)
288 vote records from 154 filers. 2 of the 153 filers that marked the item either way voted against management. 1 filer reported this item without a management mark.
COMPENSATIONIssuer
COMPENSATION: management items
Management items in this category are shown together; filers word and number them differently.
293 vote records from 157 filers. 20 of the 156 filers that marked the item either way voted against management. 1 filer reported this item without a management mark.
How the largest families voted
* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.
Questions
How did large funds vote at the Acadia Pharmaceuticals Inc. meeting?
431 Form N-PX filers reported votes at the meeting of 29 May 2024. On say-on-pay, 42 of 408 voted against management (10.3%). The family table lists each of the largest families item by item.
Is this the meeting result?
No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by Acadia Pharmaceuticals Inc. on Form 8-K.
Why are director elections shown as counts only?
Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.
Every meeting on file for Acadia Pharmaceuticals Inc.
Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing Acadia Pharmaceuticals Inc. with a meeting date within three days of 29 May 2024. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 23 Sep 2026.